Fibrosarcome du larynx - A propos d'un cas

Le fibrosarcome du larynx est une entité histologique rare, qui représente moins de 10% de tous les sarcomes des tissus mous, moins de 2 % des cancers laryngés. Cette localisation pose des problèmes diagnostique, thérapeutique et pronostique. Nous présentons un cas de fibrosarcome laryngé chez un patient de 54 ans. La confirmation histologique etimmunohistologique a été faite sur la pièce d’exérèse chirurgicale et surtout sur une confrontation anatomoclinique. La prise en charge thérapeutique est multidisciplinaire, associant la chirurgie qui doit être la plus complète sans curage ganglionnaire et la radiothérapie. Le pronostic est généralement sévère, dépend essentiellement de degré de différenciation histologique.Mots clés : fibrosarcome ; larynx ; chirurgie ; radiothérapie

Améloblastome mandibulaire place de la radiothérapie

L’améloblastome est la tumeur odontogénique la plus fréquente. il  représente 1% des tumeurs mandibulaires et maxillaires et atteint la mandibule dans 80% des cas. Son traitement se base essentiellement sur la chirurgie lorsque cela est possible. La radiothérapie est réservée aux formes inopérables localement évoluées et métastatiques. Les auteurs rapportent le cas d’un patient présentant un améloblastome mandibulaire kystique traité par radiothérapie exclusive.Mots clés: Améloblastome, mandibule, radiothérapi

Miniaturized optical fiber Bragg grating sensor interrogator based on echelle diffractive gratings

An Optical fiber Bragg grating sensor interrogation device based on monolithically integrated echelle diffractive grating and detector arrays on an InP chip is designed and prototyped. The device weighs less than 60 g and measures smaller than 45 mm × 30 mm × 15 mm, and it is specifically designed for potential integration into aerospace applications. This study discusses this device's operation principle and presents some initial experimental results reflecting its performance

Short communication: Influence of vitamins C and E on sperm motility of rabbit bucks

[EN] The objective of the study is to investigate the effect of vitamin C and E supplementation on rabbit sperm motility. Forty INAT breed bucks aged 8.5 mo were divided into 2 groups: control group (C) and treated group (T) receiving vitamins C (1 g/L) and E (1 g/L) incorporated in the drinking water. Semen was collected using an artificial vagina over 6 wk (C, total ejaculates=81; T, total ejaculates=76). The massal motility (MM) was evaluated in the fresh and raw semen. Then, the individual motility at 0 (IM0), 2 (IM2) and 4 h (IM4) after semen collection was determined in diluted semen and conserved at +4°C for the 2 groups. MM was higher in T than in C group (P=0.0012). However, the individual motilities IM0, IM2 and IM4 did not vary between the 2 groups. In conclusion, the supplementation of vitamins C and E in the drinking water for rabbit influenced only the MM in both fresh and raw semen.Najjar Ben Maâtoug, A.; Ben Saïd, S.; Najjar, T.; Kalamoun, S.; Ben Khalifa, N.; Ben Aïchae, E.; Ben Mrad, M. (2013). Short communication: Influence of vitamins C and E on sperm motility of rabbit bucks. World Rabbit Science. 21(1):45-48. doi:10.4995/wrs.2013.1174.SWORD454821

Peak grain forecasts for the US High Plains amid withering waters

ACKNOWLEDGMENTS. This paper stems from discussions during the Ettersburg Ecohydrology Workshop in Germany (October 2018), with the corresponding manuscript preparation ensuing in subsequent months. The workshop was funded by the UNIDEL Foundation, Inc. and the University of Delaware. Accordingly, partial support for this paper derived from funding for the workshop. A.M. was supported by the US NSF (Grants NSF-AGS-1644382 and NSF-IOS-175489).Peer reviewedPublisher PD

Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin

<p>Abstract</p> <p>Background</p> <p>Inflammatory breast cancer (IBC) is a distinct and aggressive form of locally-advanced breast cancer with high metastatic potential. In Tunisia, IBC is associated with a high death rate. Among the major molecular subtypes, basal breast carcinomas are poorly differentiated, have metastatic potential and poor prognosis, but respond relatively well to chemotherapy. The aim of this study was to determine the distribution of molecular subtypes in IBC and identify factors that may explain the poor prognosis of IBC.</p> <p>Methods</p> <p>To determine breast cancer subtypes we studied by immunohistochemistry the expression of 12 proteins in a series of 91 Tunisian IBC and 541 non-IBC deposited in tissue microarrays.</p> <p>Results</p> <p>We considered infiltrating ductal cases only. We found 33.8% of basal cases in IBC vs 15.9% in non-IBC (p < 0.001), 33.3% of ERBB2-overexpressing cases in IBC vs 14.5% in non-IBC (p < 0.001), and 29.3% of luminal cases in IBC vs 59.9% in non-IBC (p < 0.001). The most differentially-expressed protein between IBCs and non-IBCs was P-cadherin. P-cadherin expression was found in 75.9% of all IBC vs 48.2% of all non-IBC (p < 0.001), 95% of IBC vs 69% of non-IBC (p = 0.02) in basal cases, and 82% of IBC vs 43% of non-IBC (p < 0.001) in luminal cases. Logistic regression determined that the most discriminating markers between IBCs and non-IBCs were P-cadherin (OR = 4.9, p = 0.0019) MIB1 (OR = 3.6, p = 0.001), CK14 (OR = 2.7, p = 0.02), and ERBB2 (OR = 2.3, p = 0.06).</p> <p>Conclusion</p> <p>Tunisian IBCs are characterized by frequent basal and ERBB2 phenotypes. Surprisingly, luminal IBC also express the basal marker P-cadherin. This profile suggests a specificity that needs further investigation.</p

Management and Outcome of Cardiac and Endovascular Cystic Echinococcosis

Cardiac and vascular involvement are infrequent in classical cystic echinococcosis (CE), but when they occur they tend to present earlier and are associated with complications that may be life threatening. Cardiovascular CE usually requires complex surgery, so in low-income countries the outcome is frequently fatal. This case series describes the characteristics of cardiovascular CE in patients diagnosed and treated at a Tropical Medicine & Clinical Parasitology Center in Spain. A retrospective case series of 11 patients with cardiac and/or endovascular CE, followed-up over a period of 15 years (1995–2009) is reported. The main clinical manifestations included thoracic pain or dyspnea, although 2 patients were asymptomatic. The clinical picture and complications vary according to cyst location. Isolated cardiac CE may be cured after surgery, while endovascular extracardiac involvement is associated with severe chronic complications. CE should be included in the differential diagnosis of cardiovascular disease in patients from endemic areas. CE is a neglected disease and further studies are necessary in order to make more definite management recommendations for this rare and severe form of the disease. The authors propose a general approach based on cyst location: exclusively cardiac, endovascular or both

Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is primarily diagnosed in the latter stages of disease progression and is the third leading cause of cancer deaths worldwide. Thus, there is a need to find biomarkers of early HCC as well as the development of more effective treatments for the disease. Sphingosine-1-phosphate (S1P) is a pleiotropic lipid signaling molecule produced by two isoforms of sphingosine kinase (SphK1 and SphK2) that is involved in regulation of many aspects of mammalian physiology and pathophysiology, including inflammation, epithelial and endothelial barrier function, cancer, and metastasis, among many others. Abundant evidence indicates that SphK1 and S1P promote cancer progression and metastasis in multiple types of cancers. However, the role of SphK/S1P in HCC is less well studied. Here, we review the current state of knowledge of SphKs and S1P in HCC, including evidence for the correlation of SphK1 expression and S1P levels with progression of HCC and negative outcomes, and discuss how this information could lead to the design of more effective diagnostic and treatment modalities for HCC